000 | 00930nam a22002777a 4500 | ||
---|---|---|---|
003 | IIITD | ||
005 | 20230120155201.0 | ||
008 | 230113b xxu||||| |||| 00| 0 eng d | ||
040 | _aIIITD | ||
082 | _aREF CB 2022 | ||
100 | _aDhall, Anjali | ||
245 |
_aDevelopment of in silico tools for designing cancer immunotherapy or subunit vaccine _cby Anjali Dhall and Gajendra P.S. Raghava |
||
260 |
_aNew Delhi : _bIIIT-Delhi, _c©2022 |
||
300 |
_a156 p. : _bill. ; _c30 cm. |
||
500 | _aIncludes bibliographical references. | ||
650 | _aImmune system | ||
650 | _acytokines in cancer | ||
650 | _aHLA-binder prediction | ||
650 | _aColorectal Cancer | ||
650 | _aLung Adenocarcinoma | ||
650 | _aAmino-acid composition | ||
650 | _aimmunity against cancer | ||
700 |
_aRaghava, Gajendra Pal Singh _eAdvisor |
||
856 | _uhttps://shodhganga.inflibnet.ac.in/handle/10603/449488 | ||
942 |
_2ddc _cTH |
||
999 |
_c170861 _d170861 |